155 related articles for article (PubMed ID: 30064137)
1. Cancer-Associated Hypercoagulation Increases the Risk of Early Recurrent Stroke in Patients with Active Cancer.
Fujinami J; Ohara T; Kitani-Morii F; Tomii Y; Makita N; Yamada T; Kasai T; Nagakane Y; Nakagawa M; Mizuno T
Cerebrovasc Dis; 2018; 46(1-2):46-51. PubMed ID: 30064137
[TBL] [Abstract][Full Text] [Related]
2. Active Cancer and Elevated D-Dimer Are Risk Factors for In-Hospital Ischemic Stroke.
Yamaguchi I; Kanematsu Y; Shimada K; Korai M; Miyamoto T; Shikata E; Yamaguchi T; Yamamoto N; Yamamoto Y; Kitazato KT; Okayama Y; Takagi Y
Cerebrovasc Dis Extra; 2019; 9(3):129-138. PubMed ID: 31760390
[TBL] [Abstract][Full Text] [Related]
3. When to Screen Ischaemic Stroke Patients for Cancer.
Selvik HA; Bjerkreim AT; Thomassen L; Waje-Andreassen U; Naess H; Kvistad CE
Cerebrovasc Dis; 2018; 45(1-2):42-47. PubMed ID: 29402826
[TBL] [Abstract][Full Text] [Related]
4. The Risk Factors for Death within 6 Months After Ischemic Stroke in Patients with Cancer.
Tsuchihashi Y; Shimizu T; Akiyama H; Hagiwara Y; Soga K; Takao N; Uchino K; Yanagisawa T; Yamauchi J; Sato T; Hasegawa Y; Yamano Y
J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105365. PubMed ID: 33075707
[TBL] [Abstract][Full Text] [Related]
5. Predictors of 30-day mortality and the risk of recurrent systemic thromboembolism in cancer patients suffering acute ischemic stroke.
Nam KW; Kim CK; Kim TJ; An SJ; Oh K; Mo H; Kang MK; Han MK; Demchuk AM; Ko SB; Yoon BW
PLoS One; 2017; 12(3):e0172793. PubMed ID: 28282388
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum fibrin-monomer levels are associated with high long-term cerebrovascular event rates in acute ischemic stroke patients.
Tamura H; Hirono O; Okuyama H; Liu L; Nishiyama S; Takeishi Y; Kayama T; Kubota I
Circ J; 2007 Oct; 71(10):1573-9. PubMed ID: 17895554
[TBL] [Abstract][Full Text] [Related]
7. Cancer-Associated Stroke: The Bergen NORSTROKE Study.
Selvik HA; Thomassen L; Bjerkreim AT; Næss H
Cerebrovasc Dis Extra; 2015; 5(3):107-13. PubMed ID: 26648966
[TBL] [Abstract][Full Text] [Related]
8. D-dimer >2.785 μg/ml and multiple infarcts ≥3 vascular territories are two characteristics of identifying cancer-associated ischemic stroke patients.
Wang JY; Zhang GJ; Zhuo SX; Wang K; Hu XP; Zhang H; Qu LD
Neurol Res; 2018 Nov; 40(11):948-954. PubMed ID: 30317943
[TBL] [Abstract][Full Text] [Related]
9. Impact of D-dimer levels for short-term or long-term outcomes in cryptogenic stroke patients.
Nezu T; Kitano T; Kubo S; Uemura J; Yamashita S; Iwanaga T; Inoue T; Hosomi N; Maruyama H; Matsumoto M; Kimura K; Yagita Y
J Neurol; 2018 Mar; 265(3):628-636. PubMed ID: 29372390
[TBL] [Abstract][Full Text] [Related]
10. Hematological Abnormalities and Malnutrition Mediate Pathway between Cancer and Outcomes in Ischemic Stroke Patients.
Gon Y; Kabata D; Kawano T; Kanki H; Todo K; Sasaki T; Shintani A; Mochizuki H
J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104943. PubMed ID: 32689614
[TBL] [Abstract][Full Text] [Related]
11. Stroke and cancer: the importance of cancer-associated hypercoagulation as a possible stroke etiology.
Schwarzbach CJ; Schaefer A; Ebert A; Held V; Bolognese M; Kablau M; Hennerici MG; Fatar M
Stroke; 2012 Nov; 43(11):3029-34. PubMed ID: 22996958
[TBL] [Abstract][Full Text] [Related]
12. Ability of the number of territories involved on DWI-MRI to predict occult systemic malignancy in cryptogenic stroke patients.
Guo L; Wang L; Liu W
J Stroke Cerebrovasc Dis; 2020 Jul; 29(7):104823. PubMed ID: 32362555
[TBL] [Abstract][Full Text] [Related]
13. DWI Lesion Patterns in Cancer-Related Stroke--Specifying the Phenotype.
Schwarzbach CJ; Fatar M; Eisele P; Ebert AD; Hennerici MG; Szabo K
Cerebrovasc Dis Extra; 2015; 5(3):139-45. PubMed ID: 26648971
[TBL] [Abstract][Full Text] [Related]
14. Thrombelastography maximal clot strength could predict one-year functional outcome in patients with ischemic stroke.
Yao X; Dong Q; Song Y; Wang Y; Deng Y; Li Y
Cerebrovasc Dis; 2014; 38(3):182-90. PubMed ID: 25300785
[TBL] [Abstract][Full Text] [Related]
15. D-dimer as a predictor of early neurologic deterioration in cryptogenic stroke with active cancer.
Nam KW; Kim CK; Kim TJ; An SJ; Demchuk AM; Kim Y; Jung S; Han MK; Ko SB; Yoon BW
Eur J Neurol; 2017 Jan; 24(1):205-211. PubMed ID: 27766716
[TBL] [Abstract][Full Text] [Related]
16. D-Dimer versus International Normalized Ratio of Prothrombin Time in Ischemic Stroke Patients Treated with Sufficient Warfarin.
Yamamoto R; Nakae Y; Tanaka F; Johkura K
J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1781-1785. PubMed ID: 27103270
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers of hypercoagulability and inflammation in childhood-onset arterial ischemic stroke.
Bernard TJ; Fenton LZ; Apkon SD; Boada R; Wilkening GN; Wilkinson CC; Soep JB; Miyamoto SD; Tripputi M; Armstrong-Wells J; Benke TA; Manco-Johnson MJ; Goldenberg NA
J Pediatr; 2010 Apr; 156(4):651-6. PubMed ID: 20022340
[TBL] [Abstract][Full Text] [Related]
18. D-Dimer Trends Predict Recurrent Stroke in Patients with Cancer-Related Hypercoagulability.
Fujinami J; Nagakane Y; Fujikawa K; Murata S; Maezono K; Ohara T; Mizuno T
Cerebrovasc Dis Extra; 2024; 14(1):9-15. PubMed ID: 38061347
[TBL] [Abstract][Full Text] [Related]
19. d-dimer Level as a Predictor of Recurrent Stroke in Patients With Embolic Stroke of Undetermined Source.
Choi KH; Kim JH; Kim JM; Kang KW; Lee C; Kim JT; Choi SM; Park MS; Cho KH
Stroke; 2021 Jul; 52(7):2292-2301. PubMed ID: 33971744
[TBL] [Abstract][Full Text] [Related]
20. Clues to occult cancer in patients with ischemic stroke.
Kim SJ; Park JH; Lee MJ; Park YG; Ahn MJ; Bang OY
PLoS One; 2012; 7(9):e44959. PubMed ID: 22984594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
